Join Now

Category Archives: BioUtah News

U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.

| Tagged | Leave a comment

One Utah Health Collaborative and Utah’s BioHive Community

Governor Cox has invited Utah’s life sciences industry to engage in a bold initiative called the “One Utah Health Collaborative.” Cox understands the importance of our industry to the healthcare system and it’s appropriate that we be at the table. Below we provide more detailed information about the initiative and opportunities to participate. Background Last […]

| Leave a comment

Tempus Announces Research Collaboration with Intermountain Healthcare to Advance Precision Oncology Research

Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance research intended to improve outcomes for cancer patients. Intermountain Healthcare is leveraging Tempus’ solid tumor/normal genomic test, xT, to generate whole transcriptomic data on existing […]

| Leave a comment

KT Tape Names Jessica Klodnicki As New CEO

AMERICAN FORK, Utah, June 22, 2022 /PRNewswire/ — KT Tape®, the leader in drug-free pain relief products, today announced that after a national executive search, the company’s board of directors has appointed Jessica Klodnicki as its new chief executive officer. Klodnicki is a recognized transformative leader in the outdoor brands and consumer products industry with […]

| Leave a comment

IONIQ Unveils LUNA3, Next-Generation Early-Stage Cancer Detection Platform

IONIQ Sciences unveiled its next-generation platform called LUNA3™ for early-stage cancer detection. LUNA3 is designed to accelerate the transition of cancer testing from the hospital and doctor’s office into pharmacies and ultimately into consumers’ homes.

| Leave a comment

ATL Technology Acquires Developer of Disposable Scopes and Micro-Endoscopic Solutions, BioVision Technologies, LLC

Springville, Utah June 21, 2022—ATL Technology (“ATL”), a joint development manufacturing partner to top medical device firms, announced the acquisition of BioVision Technologies, LLC (“BioVision”). ATL has a proven track record of developing custom interconnect solutions for energy driven medical devices. Using an engineer-to-engineer approach over the last two decades, the company has been expanding […]

| Leave a comment

Utah RDAC Joins Juneteenth Health Fair

Members of the Utah Rare Disease Advisory Council (RDAC) on Monday participated in the Utah Juneteenth Holiday Health & Wellness Expo, National Sickle Cell Day, held at the Gallivan Center, in Salt Lake City, Utah. Toya Jules and Matt Pearl, RDAC members and rare disease patients, exhibited at the day long event.    “The RDAC felt it was important […]

| Leave a comment

Utah Life Sciences at BIO 2022

Utah’s life sciences industry left its mark on this week’s 2022 BIO International Convention at the San Diego Convention Center (June 13-16). Curavit, Curza, Recursion, Cytiva and Thermo Fisher showcased their companies at the convention that featured more than 3,000 companies and 100-plus panel sessions over four days. Topics included cell and gene therapies, next-gen […]

| Leave a comment

CenExel Acquires Apex Innovative Sciences

Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site Network

| Tagged | Leave a comment

Sen. Romney Opposes Drug Importation as the Senate HELP Committee Advances User Fees

The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user fee reauthorization legislation.

Also posted in Policy News | | Leave a comment

Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184

HT-6184 is a novel NEK7/NLRP3 inhibitor

| Tagged | Leave a comment

BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care

BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data

| Tagged | Leave a comment